New York, August 11, 2015 -- Moody's Investors Services today placed the ratings of Therakos, Inc. ("Therakos") under review for upgrade, including the company's B3 Corporate Family Rating ("CFR") and B3-PD Probability of Default Rating. This action follows the announcement that Therakos has entered into a definitive agreement to be acquired by a subsidiary of Mallinckrodt plc (Mallinckrodt; subsidiary Mallinckrodt International Finance SA is rated Ba3 Stable) in a transaction valued at $1.325 billion.
Vollständigen Artikel bei Moodys lesen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.